Acute effects of aerosolized S-nitrosoglutathione in cystic fibrosis. - Wikidata - wikimedia - TriplyDB

Acute effects of aerosolized S-nitrosoglutathione in cystic fibrosis.

Acute effects of aerosolized S-nitrosoglutathione in cystic fibrosis.

http://www.wikidata.org/entity/Q33958399

about

Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis S-nitrosothiol signaling in respiratory biology.Protection from experimental asthma by an endogenous bronchodilator Augmentation of CFTR maturation by S-nitrosoglutathione reductase.Phenotype of asthmatics with increased airway S-nitrosoglutathione reductase activity.Detection of S-nitroso compounds by use of midinfrared cavity ring-down spectroscopy S-Nitrosothiols increases cystic fibrosis transmembrane regulator expression and maturation in the cell surface.S-Nitrosylation signaling regulates cellular protein interactions.Biomarkers in asthma: a real hope to better manage asthma.S-nitrosoglutathione reductase in human lung cancer Determinants of exhaled breath condensate pH in a large population with asthma.Concentration-dependent effects of endogenous S-nitrosoglutathione on gene regulation by specificity proteins Sp3 and Sp1.Hsp 70/Hsp 90 organizing protein as a nitrosylation target in cystic fibrosis therapy.Endogenous S-nitrosoglutathione modifies 5-lipoxygenase expression in airway epithelial cells Metabolomic profiling reveals biochemical pathways and biomarkers associated with pathogenesis in cystic fibrosis cells.Nitric oxide-mediated dispersal in single- and multi-species biofilms of clinically and industrially relevant microorganisms Microarray analysis and functional characterization of the nitrosative stress response in nonmucoid and mucoid Pseudomonas aeruginosa.ADH IB expression, but not ADH III, is decreased in human lung cancer.Myeloperoxidase-dependent oxidative metabolism of nitric oxide in the cystic fibrosis airway.Pediatrics, surfactant, and cystic fibrosis in AJRCCM 2002.Modulation of NF-κB and hypoxia-inducible factor--1 by S-nitrosoglutathione does not alter allergic airway inflammation in mice.Nitric oxide metabolism in asthma pathophysiology.An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications.S-nitrosoglutathione supplementation to ovalbumin-sensitized and -challenged mice ameliorates methacholine-induced bronchoconstriction.Emerging drug treatments for cystic fibrosis.Pharmacological approaches to correcting the ion transport defect in cystic fibrosis.Modeling pulmonary nitric oxide exchange.Can nitric oxide-based therapy prevent bronchopulmonary dysplasia?Endothelial γ-glutamyltransferase contributes to the vasorelaxant effect of S-nitrosoglutathione in rat aorta.Stimulation of functional recovery via the mechanisms of neurorepair by S-nitrosoglutathione and motor exercise in a rat model of transient cerebral ischemia and reperfusion.Solid-phase capture for the detection and relative quantification of S-nitrosoproteins by mass spectrometry.Nitric oxide: emerging concepts about its use in cell-based therapies.Pulmonary alveolar epithelial uptake of S-nitrosothiols is regulated by L-type amino acid transporter.Repletion of S-nitrosohemoglobin improves organ function and physiological status in swine after brain death.S-nitrosoglutathione.The treatment of pulmonary diseases and respiratory-related conditions with inhaled (nebulized or aerosolized) glutathione.Glutathione dysregulation and the etiology and progression of human diseases.The role of S-nitrosoglutathione reductase (GSNOR) in human disease and therapy.Hypoxia inducible factor-1 alpha stabilization for regenerative therapy in traumatic brain injury.

P2860

Q24201222-A36E4D8F-3EAC-499D-B36C-0FBC014E29B2 Q24241156-8006C9C5-B8B0-4D16-8793-8180FDA29570 Q24650433-61E16118-BB20-440C-8C4F-120431F63199 Q24684787-84B3A46A-FFF8-4654-A673-B697A1334C59 Q30277961-86D58B04-CD90-4C16-91DF-946E17CE3828 Q30303041-F4F64EB7-F954-48D4-A5A5-7B1077F8443F Q30360171-27A81D07-09B0-4057-B0E4-93A2933CF2E8 Q30408475-55BE0979-898C-4B20-BC6F-CAC96C4EEF7E Q30412936-94DDFD4D-E549-4C65-AE3F-F40564B0DDFA Q30417360-2877046F-1B93-406E-8185-32F2CB78FB9C Q30423072-89603527-C40B-4D14-9C1A-CF550636A5B4 Q30428487-35151477-826B-49C7-B391-4075A099F0A1 Q30432918-337DC690-69F8-40C9-ABE9-ADEC527B7969 Q30433825-81DF1F9F-4A01-4398-8346-FF324682B8BC Q30439239-0FB322E8-3895-4764-BDC0-08B0678D0CD3 Q34155281-5E319A58-FDD5-4B82-AFEB-A30B03003649 Q34160541-E6A3F931-3BAE-4FAF-BCAB-85DDF9BAFBF7 Q34350755-38CEB8B6-03DF-451C-87F8-3B188A1BDE58 Q34534948-CD129BFB-8460-4445-938D-4805C83FC383 Q35055371-1B0E65D4-9FC3-45D3-8618-733F95D6781E Q35055452-14198549-BA26-4364-8D68-7D0E0015BC7E Q35103895-F2F54CAE-51B9-4A15-9BA1-98305945A4D7 Q35435319-B98AA895-DB55-471A-A66E-E23F41DE936D Q35534747-29881BF1-12D3-4201-A9F0-777EA8223456 Q35543593-6F47C01E-52D2-42CE-A2ED-74CD5CD6916C Q35602683-A39EA535-B1CE-4BDE-8619-23A2CE81BACD Q35627639-3D7941FB-6DA4-41B7-99CA-8B878F75AD10 Q35651184-23B3EE87-AD2B-4A0C-A5A7-3CA08CBBD2A2 Q36220974-0B3E25E7-EA8A-474A-98C6-E39E99631E42 Q36226859-878CB4DA-1293-4605-A82C-706101A43920 Q36318326-A9CCECBC-A80C-4508-87C8-6D78E026FCCD Q36597745-02F557E7-DE1B-4A2F-88D4-3065036D048C Q36677392-3C9C447F-DF70-439A-9BBA-0393D6E6DB7F Q36807996-CDA7241B-D5F0-4C30-9980-3518F768D3F6 Q36808426-2C2C714D-FC20-4060-B590-2793023CEE2A Q36921356-BFFB4344-7F40-486A-9381-5DB395027B00 Q37101259-BBF069F1-595C-4366-9EAE-77CA88D05C6E Q37372896-CDCC63D1-66BF-478C-938E-3C0F18334B59 Q39231089-B0E5CAF5-435D-4626-B1E3-A3D844A4E4BE Q39374463-4B8E79ED-D482-42CD-9A92-6D96FFDDDC86

P2860

Acute effects of aerosolized S-nitrosoglutathione in cystic fibrosis.

http://www.wikidata.org/entity/Q33958399

description

2002 nî lūn-bûn

@nan

2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Acute effects of aerosolized S-nitrosoglutathione in cystic fibrosis.

@ast

Acute effects of aerosolized S-nitrosoglutathione in cystic fibrosis.

@en

type

label

Acute effects of aerosolized S-nitrosoglutathione in cystic fibrosis.

@ast

Acute effects of aerosolized S-nitrosoglutathione in cystic fibrosis.

@en

prefLabel

Acute effects of aerosolized S-nitrosoglutathione in cystic fibrosis.

@ast

Acute effects of aerosolized S-nitrosoglutathione in cystic fibrosis.

@en

P1433

Q33958399-CBE3289F-993D-4C02-B1B1-409353382498

P1476

Q33958399-0AE93ABF-8C4B-4BC9-96A3-BA37D1231504

P2093

Q33958399-042D08F1-DE6F-44F7-A66A-4CFB6F61BF4C

Q33958399-47150C27-1A5F-4CD7-B717-47868160D358

Q33958399-5A34CC0B-8B53-4E97-A282-3AA5E15492A4

Q33958399-6896721A-A0EC-47B2-8EB4-7EB51DB8555C

Q33958399-7D6E3A9A-4834-429B-9F5C-2A705128B9BE

Q33958399-B9AD74FC-86E2-4C07-B9AF-188C58EE0645

P2860

Q33958399-0F65F224-50FB-4786-A52E-D6EE1A6130BF

Q33958399-1097C858-F479-4951-A74A-0AF3E89B98BF

Q33958399-1106734F-303D-42EF-A30C-BE70FB022411

Q33958399-2C501BC3-9D61-4A20-9C87-B53984D4C7BA

Q33958399-2E8D5005-38A8-494B-B03A-E13C629079C2

Q33958399-3802B3FD-F7F0-46ED-86F5-446A0680C44F

Q33958399-3D659FD2-C8AF-4803-865B-E424D1650E42

Q33958399-4311225F-0E2C-4289-86E6-FF6AAB2EAC1B

Q33958399-4D6E899E-F430-459F-9948-25C03E656F3C

Q33958399-54CB7F98-1870-4ED0-B54F-E0EBDF6F72D4

P304

Q33958399-7B61DEB4-3EEB-452C-BAB3-24CFE49AA17A

P31

Q33958399-1FDD7479-85D8-4CEC-8F4E-0E1975E10AC2

P356

Q33958399-95D8DA16-8432-4A5E-B572-9EC3F4EC6297

P407

Q33958399-97E488DD-90D9-46D2-928E-D9241885B075

P433

Q33958399-48117BC5-BA96-4022-A418-53F723CF4F71

P478

Q33958399-38B5578A-0496-4FFE-B247-ACEFCAEF20DB

P577

Q33958399-EBD56188-8BB3-43E8-A630-F0A77ADCCD70

P5875

Q33958399-216A830F-B235-45FD-9B03-F9A6C7B558AF

P698

Q33958399-D17199F0-1791-4B82-86CB-C40B3B2659C4

P921

Q33958399-CA6603EE-629A-4868-BBCD-CD74172360B4

P356

AJRCCM.165.7.2105032

P1433

American Journal of Respiratory and Critical Care Medicine

P1476

Acute effects of aerosolized S-nitrosoglutathione in cystic fibrosis.

@en

P2093

Ashley H Snyder

http://www.w3.org/2001/XMLSchema#string

Benjamin Gaston

http://www.w3.org/2001/XMLSchema#string

John F Hunt

http://www.w3.org/2001/XMLSchema#string

Jonathan S Stamler

http://www.w3.org/2001/XMLSchema#string

Marianne E McPherson

http://www.w3.org/2001/XMLSchema#string

Michael Johnson

http://www.w3.org/2001/XMLSchema#string

P2860

Endogenous nitrogen oxides and bronchodilator S-nitrosothiols in human airways

A metabolic enzyme for S-nitrosothiol conserved from bacteria to humans

Nitric oxide and thiol groups.

Endogenous airway acidification. Implications for asthma pathophysiology.

S-nitrosoglutathione increases cystic fibrosis transmembrane regulator maturation.

Expression and activity of pH-regulatory glutaminase in the human airway epithelium.

Nitrogen redox balance in the cystic fibrosis airway: effects of antipseudomonal therapy.

Export by red blood cells of nitric oxide bioactivity.

S-nitrosylation of proteins.

Exhaled nitric oxide (NO), NO synthase activity, and regulation of nuclear factor (NF)-kappaB.

P304

922-926

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1164/AJRCCM.165.7.2105032

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

165

http://www.w3.org/2001/XMLSchema#string

P577

2002-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11430505

http://www.w3.org/2001/XMLSchema#string

P698

11934715

http://www.w3.org/2001/XMLSchema#string

P921

cystic fibrosis